INS and diabetes mellitus: Activation of PPARα by fibrates successfully reduces TAG and increases HDL levels [125,126], while activation of PPARγ by thiazolidinediones (TZDs)/glitazones may improve insulin sensitivity in patients with diabetes mellitus [127,128].